UBS Maintains Buy on Labcorp Holdings, Raises Price Target to $380
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice Target
UBS analyst Kevin Caliendo maintains Labcorp Holdings (NYSE:LH) with a Buy and raises the price target from $361 to $380.
UBS analyst Kevin Caliendo maintains Labcorp Holdings (NYSE:LH) with a Buy and raises the price target from $361 to $380.